What's new

EMEA-001949-PIP02-18-M04

EMEA-001949-PIP02-18-M04

Mar 14, 2025 - 11:39
 0
EMEA-001949-PIP02-18-M04
EMEA-001949-PIP02-18-M04
Read More

Tags:

Previous Article

The Competitive Edge: Market Intelligence That Moves You Forward

Next Article

UP showcases mining technology offering

Related Posts

Human medicines European public assessment report (EPAR): Awiqli, Insulin icodec, Date of authorisation: 17/05/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025  0

Human medicines European public assessment report (EPAR): Kesimpta, ofatumumab, Date of authorisation: 26/03/2021, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Ilaris, canakinumab, Date of authorisation: 23/10/2009, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0